Another histone modifier, SMYD2 (SET and MYND domain containing 2), a histone methyltransferase, enhances cell vitality in clear cell ovarian carcinoma through ER methylation, whereas inhibiting SMYD2 induces apoptosis in these cancer cells.103. This evidence concerns the gene SMYD2 and cancer.